Rigel Pharmaceuticals, Inc. (NASDAQ: RIGL) is focused on developing innovative small molecule drugs that target hematologic disorders, cancer and rare immune diseases. The Company announced positive topline results from a phase 2 evaluation of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, intended for the...
Aeva Technologies, Inc. (NYSE: AEVA) a developer of cutting-edge optical-based sensors for autonomous vehicles, debuted on the US stock market on March 15, 2021, through its merger with SPAC InterPrivate Acquisition Corp. The Company raised close to $560 million in gross proceeds from the deal,...
Infinity Pharmaceuticals (NASDAQ: INFI) novel approach is based on Targeting Immune Suppressive Macrophages by selectively inhibiting PI3K-Gamma. The Company’s lead candidate eganelisib, is a first-in-class, oral, once-daily selective inhibitor of phosphoinositide-3-kinase gamma (PI3K-gamma), that has the potential to transform the immuno-oncology space. IPI-549 has demonstrated...
Boxlight Corporation (NASDAQ: BOXL), a leading education technology Company offering interactive solutions for the education markets worldwide, announced that two if its products Boxlight-EOS Distance Teaching Essentials and MySTEMKits 3D printing curriculum have been awarded Tech & Learning Awards of Excellence by the Tech &...
Agenus Inc (NASDAQ: AGEN), a clinical-stage immune-oncology company developing innovative therapies for treatment of cancer, announced the grant of a Fast Track designation for investigation of balstilimab [PD-1] in combination with zalifrelimab [CTLA-4] for the treatment of patients with relapsed or refractory metastatic cervical cancer. [caption...
Kannalife Inc (OTCQB: KLFE), a biopharmaceutical Company developing CBD-based therapeutics for the treatment of neurodegenerative and neuropathic pain disorders, announced the grant of a patent Chinese Patent CN106456573B specific to "Novel Functionalized 1,3-Benzene Diols and their Method of Use for the Treatment of Hepatic Encephalopathy",...
Cannabics Pharmaceuticals (OTCQB: CNBX), an early-stage Biotechnology Company focussed on creating cannabinoid-based therapeutics and therapies for treatment of cancer, announced the signing of a Memorandum of Understanding (MoU) with RCK Medical Cannabis, an Israeli cannabis company that creates tailor-made medical cannabis strains and hybrid seeds...
SeaSpine Holdings Corporation (NASDAQ: SPNE), a Company leveraging technology to develop surgical solutions for spinal disorders, announced the signing of a strategic partnership with 7D Surgical Inc, a Toronto-based developer of advanced image guidance technologies and machine-vision-based registration algorithms. 7D Surgical’s proprietary Machine-vision Image Guided...
Cure Pharmaceutical (OTCQB: CURR), a Company leveraging its proprietary drug dosage forms and delivery systems to create innovative therapeutics in collaboration with leading biotech and pharmaceutical companies, announced the signing of an exclusive licensing agreement with ReLeaf Europe, a leading European Medicinal Cannabis Company. ReLeaf...
The Meet Group (NASDAQ: MEET), a leading provider of interactive livestreaming solutions, which operates a portfolio of Social Entertainment platforms, announced its collaboration and welcomed a new tool from Microsoft (NASDAQ: MSFT), which helps detect on-line predatory behaviour aimed at child exploitation, using an algorithm-based...
